Managing children skin and soft tissue infections;Propositions thérapeutiques pour le traitement des infections cutanées bactériennes

Archives de Pediatrie

Volumn 15, Issue SUPPL. 2, 2008, Pages

  Moulin, F ^a   Quinet, B ^b   Raymond, J ^c   Gillet, Y ^d   Cohen, R ^e  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

^c Laboratoire de Microbiologie   (France)

^d Service Urgences et Réanimations Pédiatriques   (France)

^e CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFADROXIL; CEFATRIZINE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FUSIDATE SODIUM; FUSIDIC ACID; ISOPENICILLIN N; JOSAMYCIN; LINEZOLID; MACROLIDE; MUPIDERM; OXACILLIN; PRISTINAMYCIN; PSEUDOMONIC ACID; REPTAMULINE; RETAPAMULIN; ROXITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ABSCESS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; ECZEMA; FURUNCULOSIS; GRAM POSITIVE BACTERIUM; HUMAN; HYPOTENSION; IMPETIGO; IMPETIGO BULLOSA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NECROTIZING DERMOHYPODERMITIS; NECROTIZING FASCIITIS; PALLOR; PHARMACODYNAMICS; PREVALENCE; SKIN INFECTION; SKIN INFLAMMATION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; TACHYCARDIA; THROMBOSIS; TOXIC EPIDERMAL NECROLYSIS;

ADMINISTRATION, ORAL; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CELLULITIS; CEPHALOSPORINS; CHILD; DRUG RESISTANCE, BACTERIAL; EPIDERMAL NECROLYSIS, TOXIC; FASCIITIS, NECROTIZING; FURUNCULOSIS; FUSIDIC ACID; HUMANS; IMPETIGO; INJECTIONS, INTRAVENOUS; MACROLIDES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; PENICILLINS; PRISTINAMYCIN; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SCALDED SKIN SYNDROME; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 55649095299     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-693X(08)74218-0     Document Type: Article

References (14)

1. Conférence de consensus. Erysipèle et Fasciite nécrosante : prise en charge. Med Mal Infect 4 (2000) 245-271
2. Bingen E., Bidet P., Mihaila-Amrouche L., et al. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 48 (2004) 3559-3562
3. Bernard P., Jarlier V., and Santerrre-Henriksen A. Sensibilité aux antibiotiques des souches de Staphylococcus aureus responsables d'infections cutanées communautaires. Ann Dermatol Venereol 135 (2008) 13-19
4. Prescription des antibiotiques par voie locale dans les infections cutanées bactériennes primitives et secondaires, Recommandation de l'AFSSAPS 2004, http://agmed.sante.gouv.fr/pdf/5/rbp/dermagu.pdf
5. Gorwitz RJ, Jernigan D, Powers JH, et al. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html
6. Jacobs M.R., Jones R.N., and Giordano P.A. Oral beta-lactams applied to uncomplicated infections of skin and skin structure. Diagn microbial Infect Dis 57 (2007) 55S-65S
7. Pichichero M.E. A review of evidence supporting the American academy of pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 115 (2005) 1048-1457
8. Daum R. Skin and soft-tissue infections caused by methicillinresistant Staphylococcus aureus. N Engl J Med 357 (2007) 380-390
9. Kaplan S.L., Afghani B., Lopez P., et al. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infection in children. Pediatr Infect Dis J 22 (2003) S178-S185
10. American Academy of Pediatrics Committee on Infectious Diseases Severe invasive group. A streptococal infections: a subject review. Pediatrics 101 (1998) 136-140
11. Dumitrescu O., Boisset S., Badiou C., et al. effect of antibiotics on Staphylococcus producing Penton Valentine leukocidin. Antimicro Agents Chemother 51 (2007) 1515-1519
12. Ladhani S., Joannou C., Lochrie D., et al. Clinical, microbial and biochemical aspects of the exfoliative toxins causing staphyloccal scalded-skin syndrome. Clin Microb Rev 12 (1999) 224-232
13. Lee M.C., Rios A.M., Aten M.F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 23 (2004) 123-127
14. Bingen E., Mariani-Kurkjian P., and Nebbab B. Comment optimiser le taux sérique de vancomycine dans le traitement des infections à Staphylococcus aureus ?. Med Mal Infect 36 (2006) 439-442